Loading the records…
Loading the records…
HR10024, introduced in the House and referred to Energy and Commerce and Ways and Means, would require health insurers and Medicare Advantage organizations to publicly disclose coverage request rejection information. This early-stage transparency bill imposes compliance costs and reputational risk on major insurers like UNH, HUM, CVS, and CI, but has no direct funding or immediate revenue impact. The market impact is limited to administrative burden and potential public scrutiny of denial rates.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
The bill's introduction is unlikely to move stock prices materially. For $UNH, with $371.6B revenue, incremental compliance costs are trivial. For $HUM, which is more concentrated in MA, the impact is relatively larger but still not transformative. Any sell-off would be shallow and short-lived. Investors should monitor whether the bill gains committee traction or cosponsors—if it does, the regulatory risk to MA insurers could rise, but current odds are low.
What happened: On August 3, 2026, Rep. Hinson (R-IA) introduced HR10024, which amends the Public Health Service Act and Social Security Act to require health insurance issuers and Medicare Advantage organizations to make publicly available information about coverage request rejections. The bill was referred to the Energy and Commerce and Ways and Means committees. It is at the earliest legislative stage with no cosponsors and no committee action yet.
The money trail: This bill authorizes no funding. It is a regulatory mandate on private insurers, not a spending program. The cost to insurers is administrative—implementing systems to compile and publish rejection data. There is no appropriation involved, so the federal government spends nothing directly. The financial impact is a compliance cost on affected companies, which is likely to be modest relative to their revenue bases.
Convergence: No related signals or procurement data were provided. This is an isolated transparency bill. However, it aligns with a broader regulatory trend of increasing healthcare pricing and coverage transparency, though no specific White House action or companion bill is present. The absence of convergence means the bill should be analyzed on its own merits.
Structural winners and losers: The clear losers are Medicare Advantage insurers that will face new disclosure requirements. UNH, HUM, CVS (Aetna), and CI are the public pure-plays or major players in this space. The bill does not create any winners—consumers may benefit from transparency, but no public company is directly advantaged. The impact is a mild negative administrative burden and potential reputational risk.
Timeline: The bill is in early stages. It will need committee hearings, markup, and a floor vote in the House, then Senate passage and presidential action. Given the 119th Congress is halfway through (2026), the probability of enactment in this session is low. Most similar transparency bills stall. If it does pass, implementation would occur after a rulemaking period, likely 1-2 years after enactment.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $1.8B Department of Health and Human Services Contract Vehicle
OHIO DEPARTMENT OF MEDICAID: $28.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $1.2B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $2.1B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $4.0B Department of Health and Human Services Federal Award
MULTIPLE RECIPIENTS: $1.4B Department of Health and Human Services Federal Award
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →